We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

2 hedge funds and large institutions have $12K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3 → 2 (-1)

78% less call options, than puts

Call options by funds: $73K | Put options by funds: $335K

94% less capital invested

Capital invested by funds: $210K → $12K (-$198K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
$73K
Puts
$335K
Net Calls
-$262K
Net Calls Change
-$2.78M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$157K
2
TRCT
Tower Research Capital (TRC)
New York
-$511
Name Holding Trade Value Shares
Change 		Change in
Stake
Twin Tree Management
1
Twin Tree Management
Texas
$12K – – –
SM
2
Sabby Management
Florida
– -$157K -285,414 Closed
TRCT
3
Tower Research Capital (TRC)
New York
– -$511 -800 -91%

SGYPW Hedge Fund Activity: Q2 2016 in Review

2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q2 2016, worth a combined $12K — down 94% from $210K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SGYPW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $157K sold.

  • 2 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q2 2016, down from 3 in Q1 2016.
  • Funds reported $12K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q2 2016, down 94% quarter-over-quarter.
  • 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q2 2016 and 1 closed out, a net change of -1 holder.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q2 2016 was Sabby Management, an estimated $157K sold.

Based on aggregated 13F filings for Q2 2016.